On April 27, 2023, Shanghai Labway Clinical Laboratory Co., Ltd cancelled the transaction. The cancellation has been approved in the 14th meeting of the third board of directors and the 12th meeting of the third board of supervisors.
Shanghai Labway Clinical Laboratory Co., Ltd
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 CNY | -0.20% | +8.19% | -26.49% |
1st Jan change | Capi. | |
---|---|---|
-26.49% | 540M | |
-16.58% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.82% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.72% | 1.03B |
- Stock Market
- Equities
- 301060 Stock
- News Shanghai Labway Clinical Laboratory Co., Ltd
- Shanghai Labway Clinical Laboratory Co., Ltd cancelled the transaction announced on September 1, 2022